Ozempic Drugmaker BOOSTS Lobbying As It Seeks Medicare COVERAGE For Weight Loss Drugs
Novo Nordisk, the maker of the weight loss drug Wegovy and diabetes medication Ozempic, went on a federal lobbying spending spree in the first six months of 2023.
The Danish drugmaker is pushing Congress to pass a bill that would nix Medicare restrictions on covering weight
management treatments. Novo Nordisk has hired three new lobbying firms over the past three months, all of which disclosed being solely focused on issues related to obesity and Medicare coverage of anti-obesity drugs.
A 2003 law excludes weight-loss drugs from coverage under Medicare, the federal program that provides health coverage for older Americans. But since the American Medical Association recognized obesity as a disease in 2013, momentum has been building to shift federal policy.
-
7:58
LongGameHealth
11 months ago $0.53 earnedOzempic and Weight Loss - Pharmacist Explains
794 -
9:54
Biblical Prescriptions for Life
10 months agoOzempic: The Magic Weight Loss Medicine We've Been Waiting For?
8702 -
3:13
MWS
3 months agoWeight Loss Drug Zepbound Officially in a Shortage | FDA Confirms
30 -
25:04
The Frontline Army
5 months agoOzempic, Big Pharma’s Latest Fat-Buster Swindle
5.58K3 -
6:00
Don Khan Swaylo
9 months agoOzempic Makes Novo Nordisk the BIGGEST Company in Europe! FAST Weight Loss is BIG Business!
164 -
0:44
JTN2020
11 months agoOver half of US adults want insurers to cover weight-loss drugs, new poll finds
91 -
5:36
Don Khan Swaylo
1 year agoANOTHER Side Effect of Ozempic Discovered! HOW MUCH IS TOO MUCH FOR the Miracle Weight Loss Drug?
1.08K1 -
6:53
LongGameHealth
11 months ago $0.07 earnedOzempic - Pharmacist Explains
245 -
13:11
Biblical Prescriptions for Life
1 year agoThe Doctor's thoughts on popular weight loss drugs like Ozempic
413 -
11:13
DrDavidMarquis
1 year agoWeight Loss with Ozempic: Risks vs Benefits
85